Development of canine herpesvirus based antifertility vaccines for foxes using bacterial artificial chromosomes.
Using bacterial artificial chromosome (BAC) technology, a canine herpesvirus (CHV)-based recombinant vaccine vector was produced for the development of an antifertility vaccine for foxes. Infectious viruses were recovered following transfection of canid cells with a BAC plasmid carrying the complete CHV genome. In vitro growth characteristics of BAC-derived viruses were similar to that of wildtype (wt)-CHV. Two recombinant antigens, fox zona pellucida protein subunit 3 (fZPC) and enhanced green fluorescent protein (EGFP) as control antigen, were inserted into thymidine kinase (TK) locus of the CHV genome and shown to be efficiently expressed in vitro. Inoculation of foxes with transgenic CHVs induced CHV specific antibodies, but was innocuous and failed to elicit transgene-specific antibody responses. Infectious virus or viral DNA was not detected in mucosal secretions or tissues of vaccinated foxes. The CHV-BAC system proved to be a quick and reliable method to manipulate the CHV genome. It will help to readily apply changes in the vector design in order to improve virus replication in vivo.
Strive
Tanja
T
Pest Animal Control Cooperative Research Centre CSIRO Sustainable Ecosystems, Canberra, ACT, Australia. tanja.strive@csiro.au
Hardy
Christopher M
CM
French
Nigel
N
Wright
John D
JD
Nagaraja
Nitin
N
Reubel
Gerhard H
GH
D000818:Animals; D001831:Body Temperature; D001835:Body Weight; D002478:Cells, Cultured; D022202:Chromosomes, Artificial, Bacterial; D004279:DNA, Viral / Q000032:analysis; D004285:Dogs; D004926:Escherichia coli / Q000235:genetics; D005589:Foxes; D016679:Genome, Viral; D002184:Herpesvirus 1, Canid / Q000235:genetics* / Q000276:immunology; D013937:Thymidine Kinase / Q000235:genetics; D022642:Vaccines, Contraceptive / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology*; D015044:Zona Pellucida / Q000276:immunology*
D004279:DNA, Viral; D022642:Vaccines, Contraceptive; D014614:Vaccines, Synthetic; D013937:Thymidine Kinase